FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3178111982> ?p ?o ?g. }

• W3178111982 abstract "Background: Non-small cell lung cancer (NSCLC) represents the 80-85% of the lung cancer. Cisplatin-based chemotherapy is the paradigm of NSCLC treatment; however, it also induces de novo DNA hyper methylation that is associated with gene expression regulation. We have previously reported that the loss of IGFBP-3 expression by promoter hypermethylation results in reduced NSCLC cells sensitivity to cisplatin. Liquid biopsy has gained increasing attention in recent years, as it is a convenient and minimally invasive alternative to interrogate tumor free DNA (ctDNA).Objective: To study the correlation between the IGFBP-3 gene promoter methylation levels in ctDNA and paired tumor tissues from NSCLC patients at advanced stages.Methods: 66 FFPE/plasma prospective paired samples from stages III-IV NSCLC patients have been collected in a prospective study at Hospital La Paz, together with the associated clinical history. ctDNA and tumor tissue DNA was isolated and bisulfite modified. Methylation levels at IGFBP3-promoter was assessed by qMSP following the next equation: Cmeth = 100/[1+2(CTCG - CTTG)]. A validation cohort of 56 retrospective samples from national biobanks was included.Results: Our first result indicate that mIGFBP-3 assessment in DNA from tumor tissue is an indicator of a worse prognosis, since 75% of patients with stages IIIC/IV present hipermethylated levels in comparison with 25% of patients in stages IIIA/IIIB, (p = 0.035). When analyzing the ctDNA, we found that 87% of patients with mIGFBP-3 progress to the disease (p=0.001), although those patients with mIGFP-3 ≤ 35.5%, present a higher Overall Survival (OS) (p=0.026). In terms of therapy response we observed that those patients with methylation levels in tissue ≤ P75 (74.7%) have a greater survival when they receive QT vs QT + RT (n = 35) (p=0.364; HR = 0.514), in fact, 80% of patients receiving only QT are still alive at 365 days versus those receiving QT + RT. Merged data including the validation cohort reached the statistical significance (p=0.042). We also found a reduced in the risk of death by 82.2% (p=0.01) and 85.9% (p=0.002) respectively, in the patients that following a specific RECITS criteria (patients who progress or have stable disease), presented mIGFBP3 levels in tissue ≤ P50 ( 12,2 %) and in ctDNA ≤ P75 (15,6%).Conclusions: Our results indicate that mIGFBP-3 is a good prognostic biomarker in patients with NSCLC at advanced stages in both, tissue and circulating tumor DNA. Furthermore, its presence in liquid biopsy may be useful as a biomarker for bad prognosis. In summary, methylation status of IGFBP3 may provide a useful clinical tool for deciding on a concomitant radiotherapy applied in both, tissue and in liquid biopsy. This tool also provides a non-invasive and novel approach for the monitoring of NSCLC patients to support the use of the RECIST criteria in order to indicate continuity in QT treatment.Citation Format: Olga Pernía, Rocío Rosas, Julia Jiménez, Itsaso Losantos, Isabel Esteban, Patricia Cruz Castellanos, Oliver Higuera, Tatiana Juste, Olga Vera Puente, Ángel Diaz Lagares, Javier de Castro, Inmaculada ibañez de Caceres. Role of mIGFBP-3 in the clinical monitoring of non-small cell lung cancer patients at advanced stages [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2021; 2021 Apr 10-15 and May 17-21. Philadelphia (PA): AACR; Cancer Res 2021;81(13_Suppl):Abstract nr 2095." @default.
• W3178111982 created "2021-07-19" @default.
• W3178111982 creator A5009399360 @default.
• W3178111982 creator A5010318754 @default.
• W3178111982 creator A5011258008 @default.
• W3178111982 creator A5015181319 @default.
• W3178111982 creator A5017508230 @default.
• W3178111982 creator A5018623130 @default.
• W3178111982 creator A5020076808 @default.
• W3178111982 creator A5036536297 @default.
• W3178111982 creator A5041402883 @default.
• W3178111982 creator A5081814994 @default.
• W3178111982 creator A5086551845 @default.
• W3178111982 creator A5087266867 @default.
• W3178111982 date "2021-07-01" @default.
• W3178111982 modified "2023-10-18" @default.
• W3178111982 title "Abstract 2095: Role of mIGFBP-3 in the clinical monitoring of non-small cell lung cancer patients at advanced stages" @default.
• W3178111982 doi "https://doi.org/10.1158/1538-7445.am2021-2095" @default.
• W3178111982 hasPublicationYear "2021" @default.
• W3178111982 type Work @default.
• W3178111982 sameAs 3178111982 @default.
• W3178111982 citedByCount "0" @default.
• W3178111982 crossrefType "proceedings-article" @default.
• W3178111982 hasAuthorship W3178111982A5009399360 @default.
• W3178111982 hasAuthorship W3178111982A5010318754 @default.
• W3178111982 hasAuthorship W3178111982A5011258008 @default.
• W3178111982 hasAuthorship W3178111982A5015181319 @default.
• W3178111982 hasAuthorship W3178111982A5017508230 @default.
• W3178111982 hasAuthorship W3178111982A5018623130 @default.
• W3178111982 hasAuthorship W3178111982A5020076808 @default.
• W3178111982 hasAuthorship W3178111982A5036536297 @default.
• W3178111982 hasAuthorship W3178111982A5041402883 @default.
• W3178111982 hasAuthorship W3178111982A5081814994 @default.
• W3178111982 hasAuthorship W3178111982A5086551845 @default.
• W3178111982 hasAuthorship W3178111982A5087266867 @default.
• W3178111982 hasConcept C104317684 @default.
• W3178111982 hasConcept C121608353 @default.
• W3178111982 hasConcept C126322002 @default.
• W3178111982 hasConcept C143998085 @default.
• W3178111982 hasConcept C150194340 @default.
• W3178111982 hasConcept C188816634 @default.
• W3178111982 hasConcept C189235521 @default.
• W3178111982 hasConcept C190727270 @default.
• W3178111982 hasConcept C2775934546 @default.
• W3178111982 hasConcept C2776256026 @default.
• W3178111982 hasConcept C2776694085 @default.
• W3178111982 hasConcept C2778239845 @default.
• W3178111982 hasConcept C2779529041 @default.
• W3178111982 hasConcept C33288867 @default.
• W3178111982 hasConcept C502942594 @default.
• W3178111982 hasConcept C55493867 @default.
• W3178111982 hasConcept C71924100 @default.
• W3178111982 hasConcept C86803240 @default.
• W3178111982 hasConceptScore W3178111982C104317684 @default.
• W3178111982 hasConceptScore W3178111982C121608353 @default.
• W3178111982 hasConceptScore W3178111982C126322002 @default.
• W3178111982 hasConceptScore W3178111982C143998085 @default.
• W3178111982 hasConceptScore W3178111982C150194340 @default.
• W3178111982 hasConceptScore W3178111982C188816634 @default.
• W3178111982 hasConceptScore W3178111982C189235521 @default.
• W3178111982 hasConceptScore W3178111982C190727270 @default.
• W3178111982 hasConceptScore W3178111982C2775934546 @default.
• W3178111982 hasConceptScore W3178111982C2776256026 @default.
• W3178111982 hasConceptScore W3178111982C2776694085 @default.
• W3178111982 hasConceptScore W3178111982C2778239845 @default.
• W3178111982 hasConceptScore W3178111982C2779529041 @default.
• W3178111982 hasConceptScore W3178111982C33288867 @default.
• W3178111982 hasConceptScore W3178111982C502942594 @default.
• W3178111982 hasConceptScore W3178111982C55493867 @default.
• W3178111982 hasConceptScore W3178111982C71924100 @default.
• W3178111982 hasConceptScore W3178111982C86803240 @default.
• W3178111982 hasLocation W31781119821 @default.
• W3178111982 hasOpenAccess W3178111982 @default.
• W3178111982 hasPrimaryLocation W31781119821 @default.
• W3178111982 hasRelatedWork W1178848704 @default.
• W3178111982 hasRelatedWork W1519915707 @default.
• W3178111982 hasRelatedWork W1603166532 @default.
• W3178111982 hasRelatedWork W2080287554 @default.
• W3178111982 hasRelatedWork W2112163692 @default.
• W3178111982 hasRelatedWork W2381460883 @default.
• W3178111982 hasRelatedWork W2480785262 @default.
• W3178111982 hasRelatedWork W2614997073 @default.
• W3178111982 hasRelatedWork W2902808460 @default.
• W3178111982 hasRelatedWork W3161067307 @default.
• W3178111982 isParatext "false" @default.
• W3178111982 isRetracted "false" @default.
• W3178111982 magId "3178111982" @default.
• W3178111982 workType "article" @default.